CorrectionErratum
Correction to “R406, an Orally Available Spleen Tyrosine Kinase Inhibitor Blocks Fc Receptor Signaling and Reduces Immune Complex-Mediated Inflammation”
Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 326; DOI: https://doi.org/10.1124/jpet.112.05er13